epigallocatechin gallate

nuclear factor kappa B subunit 1 ; Homo sapiens







90 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35268073 EGCG Prevents the Onset of an Inflammatory and Cancer-Associated Adipocyte-like Phenotype in Adipose-Derived Mesenchymal Stem/Stromal Cells in Response to the Triple-Negative Breast Cancer Secretome. 2022 Mar 5 1
2 35289676 Involvement of microRNA modifications in anticancer effects of major polyphenols from green tea, coffee, wine, and curry. 2022 Mar 15 2
3 34054222 Potential protective mechanisms of green tea polyphenol EGCG against COVID-19. 2021 Aug 1
4 31999881 Catechins reduce inflammation in lipopolysaccharide-stimulated dental pulp cells by inhibiting activation of the NF-κB pathway. 2020 May 1
5 32606686 Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer. 2020 4
6 32726662 Epigallocatechin gallate suppresses inflammation in human coronary artery endothelial cells by inhibiting NF-κB. 2020 Oct 1 3
7 32924251 PEBP1 suppresses HIV transcription and induces latency by inactivating MAPK/NF-κB signaling. 2020 Nov 5 2
8 33038311 The tea catechin epigallocatechin gallate inhibits NF-κB-mediated transcriptional activation by covalent modification. 2020 Nov 30 4
9 33074673 N-Ethyl-2-Pyrrolidinone-Substituted Flavan-3-Ols with Anti-inflammatory Activity in Lipopolysaccharide-Stimulated Macrophages Are Storage-Related Marker Compounds for Green Tea. 2020 Oct 28 2
10 33113766 Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers. 2020 Oct 25 2
11 33425912 EGCG Enhanced the Anti-tumor Effect of Doxorubicine in Bladder Cancer via NF-κB/MDM2/p53 Pathway. 2020 5
12 30741544 (-)-Epigallocatechin Gallate (EGCG) Enhances the Sensitivity of Colorectal Cancer Cells to 5-FU by Inhibiting GRP78/NF-κB/miR-155-5p/MDR1 Pathway. 2019 Mar 6 4
13 31252129 Protective effect of green tea catechin against urban fine dust particle-induced skin aging by regulation of NF-κB, AP-1, and MAPKs signaling pathways. 2019 Sep 2
14 31374144 Epigallocatechin-3-Gallate Attenuates Microglial Inflammation and Neurotoxicity by Suppressing the Activation of Canonical and Noncanonical Inflammasome via TLR4/NF-κB Pathway. 2019 Nov 2
15 29552308 EGCG inhibited bladder cancer T24 and 5637 cell proliferation and migration via PI3K/AKT pathway. 2018 Feb 23 1
16 27881007 EGCG sensitizes human nasopharyngeal carcinoma cells to TRAIL-mediated apoptosis by activation NF-κB. 2017 3
17 28040581 EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9. 2017 Mar 4
18 28076319 Impact of nutrition on pollutant toxicity: an update with new insights into epigenetic regulation. 2017 Mar 1 2
19 28367625 Epigallocatechin-3-gallate Reduces Scavenger Receptor A Expression and Foam Cell Formation in Human Macrophages. 2017 Apr 19 1
20 28432554 Epigallocatechin gallate protects BEAS-2B cells from lipopolysaccharide-induced apoptosis through upregulation of gastrin-releasing peptide. 2017 Oct 2
21 28504421 Bioinformatics Analysis on Molecular Mechanism of Green Tea Compound Epigallocatechin-3-Gallate Against Ovarian Cancer. 2017 Jul 1
22 28713815 Bioinformatic Prediction of Possible Targets and Mechanisms of Action of the Green Tea Compound Epigallocatechin-3-Gallate Against Breast Cancer. 2017 1
23 26878794 EGCG prevents PCB-126-induced endothelial cell inflammation via epigenetic modifications of NF-κB target genes in human endothelial cells. 2016 Feb 3
24 27791197 Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity. 2016 Nov 29 1
25 25487615 (-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-κB p65 inactivation. 2015 Apr 7
26 25550533 Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling. 2015 Jan 1
27 25625511 EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells. 2015 Jan 23 1
28 24402647 Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway. 2014 Mar 1
29 24481129 Epigallocatechin-3-gallate inhibits TF and TNF-α expression induced by the anti-β2GPI/β2GPI complex in human THP-1 cells. 2014 Apr 2
30 24508477 Curcumin and (-)-epigallocatechin-3-gallate attenuate acrylamide-induced proliferation in HepG2 cells. 2014 Apr 1
31 24852948 Green tea polyphenol epigallocatechin-3-gallate inhibits TNF-α-induced production of monocyte chemoattractant protein-1 in human umbilical vein endothelial cells. 2014 3
32 24971028 Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells. 2014 2
33 23135610 (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity. 2013 Jan 3
34 23141425 EGCG inhibits CTGF expression via blocking NF-κB activation in cardiac fibroblast. 2013 Jan 15 4
35 23260235 Epigallocatechin gallate attenuates interstitial cystitis in human bladder urothelium cells by modulating purinergic receptors. 2013 Jul 1
36 23395866 EGCG attenuates high glucose-induced endothelial cell inflammation by suppression of PKC and NF-κB signaling in human umbilical vein endothelial cells. 2013 Mar 21 6
37 23410590 Cytoprotective effect of epigallocatechin-3-gallate against deoxynivalenol-induced toxicity through anti-oxidative and anti-inflammatory mechanisms in HT-29 cells. 2013 Jun 1
38 21698451 Inhibitory effect of Epigallocatechin gallate on ovarian cancer cell proliferation associated with aquaporin 5 expression. 2012 Feb 1
39 21833768 Epigallocatechin-3-O-gallate inhibits the production of thymic stromal lymphopoietin by the blockade of caspase-1/NF-κB pathway in mast cells. 2012 Jun 1
40 22101170 Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro. 2012 Jan 1
41 22284780 Advances in the treatment of ovarian cancer: a potential role of antiinflammatory phytochemicals. 2012 Jan 2
42 22480519 EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway. 2012 May 22 3
43 22707304 EGCG targeting efficacy of NF-κB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cells. 2012 Dec 6
44 22843790 Epigallocatechin-3-gallate diminishes cytokine-stimulated Cyr61 expression in human osteoblastic cells: a therapeutic potential for arthritis. 2012 Nov 3
45 22941057 Epigallocatechin-3-gallate inhibits bladder cancer cell invasion via suppression of NF-κB‑mediated matrix metalloproteinase-9 expression. 2012 Nov 3
46 21364905 Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells. 2011 Feb 18 3
47 21682898 Epigallocatechin-3-gallate suppresses the global interleukin-1beta-induced inflammatory response in human chondrocytes. 2011 Jun 17 1
48 21776820 Tea polyphenols induce apoptosis through mitochondrial pathway and by inhibiting nuclear factor-kappaB and Akt activation in human cervical cancer cells. 2011 2
49 21982776 Green tea polyphenol epigallocatechin-3-gallate suppresses melanoma growth by inhibiting inflammasome and IL-1β secretion. 2011 Oct 28 3
50 22022384 Green tea catechins reduce invasive potential of human melanoma cells by targeting COX-2, PGE2 receptors and epithelial-to-mesenchymal transition. 2011 2